Acclinate
Platform helping biopharmaceutical companies access and engage diverse clinical trial participants.
What they do
Acclinate leverages digital community engagement to help pharmaceutical sponsors improve clinical trial diversity. The company utilises its proprietary platform to build trust and educate underrepresented communities, ensuring clinical trials reflect real world patient demographics.
The record
- Vertical
- Clinical Trials
- Sub-segment
- Patient recruitment
- Product type
- Service
- Stage
- Series A
- Headquarters
- Birmingham, United States
- Region
- North America
- Founded
- 2020
- Total funding
- $7M raised
Notable investors: Overline, Bronze Valley, Collab Capital.